COVID‐19 associated EBV reactivation and effects of ganciclovir treatment

M Meng, S Zhang, X Dong, W Sun… - Immunity …, 2022 - Wiley Online Library
… Our study suggested that ganciclovir was safe in patients with COVID-19, because there …
between ganciclovir-treated and ganciclovir-free patients. In addition, ganciclovir treatment did …

Therapeutic drug monitoring of ganciclovir: where are we?

AG Märtson, AE Edwina, HY Kim… - Therapeutic Drug …, 2022 - journals.lww.com
Ganciclovir is the mainstay of therapy for the prophylaxis and treatment of Cytomegalovirus.
… The purpose of this narrative review was to give an overview of ganciclovir TDM, available …

The effect of (val) ganciclovir on hearing in congenital cytomegalovirus: a systematic review

E De Cuyper, F Acke, A Keymeulen… - The …, 2022 - Wiley Online Library
Objective To search for existing evidence of a beneficial effect of (val)ganciclovir on hearing
in children with congenital cytomegalovirus (cCMV) infection and to identify future research …

2% Ganciclovir eye drops control Posner-Schlossman syndrome relapses with/without cytomegalovirus intraocular reactivation

Q Sheng, R Zhai, X Fan, X Kong - Frontiers in Medicine, 2022 - frontiersin.org
… Preventive ganciclovir application … 2% ganciclovir concentration helped maintaining good
prognosis (15, 16). We are aiming at proposing detailed treatment schedule for 2% ganciclovir

A systematic review of the clinical pharmacokinetics, pharmacodynamics and toxicodynamics of ganciclovir/valganciclovir in allogeneic haematopoietic stem cell …

PR Selby, S Shakib, SL Peake, MS Warner… - Clinical …, 2021 - Springer
Background Ganciclovir (GCV) and valganciclovir (VGCV) are the first-line agents used to
prevent and treat cytomegalovirus (CMV) infection in allogeneic haematopoietic stem cell …

Ganciclovir therapeutic drug monitoring in transplant recipients

AG Märtson, AE Edwina, JGM Burgerhof… - Journal of …, 2021 - academic.oup.com
… val)ganciclovir TDM in a tertiary care hospital, a high variability of ganciclovir concentrations
was … It has been suggested to monitor ganciclovir exposure in specific patient groups, where …

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation

L Papazian, S Jaber, S Hraiech, K Baumstarck… - Annals of intensive …, 2021 - Springer
… The main objective of this study was to determine whether preemptive intravenous
ganciclovir increases the number of ventilator-free days in patients with CMV blood reactivation. …

Pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring of valganciclovir and ganciclovir in transplantation

B Franck, J Autmizguine, P Marquet… - Clinical …, 2022 - Wiley Online Library
… exposure/safety relationships of ganciclovir and valganciclovir in transplant recipients …
ganciclovir TDM in adults and pediatrics transplant recipients. The pharmacokinetics of ganciclovir

Moving past ganciclovir and foscarnet: advances in CMV therapy

M Hakki - Current hematologic malignancy reports, 2020 - Springer
Purpose of Review CMV DNA polymerase inhibitors such as ganciclovir and foscarnet have
dramatically reduced the burden of CMV infection in the HCT recipient. However, their use …

Poloxamer 188–quercetin formulations amplify in vitro ganciclovir antiviral activity against cytomegalovirus

A Kjar, I Wadsworth, E Vargis, DW Britt - Antiviral Research, 2022 - Elsevier
… Treatment of human cytomegalovirus (CMV) infection requires long-term administration of
nucleoside analog antivirals such as ganciclovir (GCV), a therapy frequently limited by GCV-…